A human Dravet syndrome model from patient induced pluripotent stem cells

Norimichi Higurashi, Taku Uchida, Christoph Lossin, Yoshio Misumi, Yohei Okada, Wado Akamatsu, Yoichi Imaizumi, Bo Zhang, Kazuki Nabeshima, Masayuki X. Mori, Shutaro Katsurabayashi, Yukiyoshi Shirasaka, Hideyuki Okano, Shinichi Hirose

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Background: Dravet syndrome is a devastating infantile-onset epilepsy syndrome with cognitive deficits and autistic traits caused by genetic alterations in SCN1A gene encoding the α-subunit of the voltage-gated sodium channel Nav1.1. Disease modeling using patient-derived induced pluripotent stem cells (iPSCs) can be a powerful tool to reproduce this syndrome's human pathology. However, no such effort has been reported to date. We here report a cellular model for DS that utilizes patient-derived iPSCs. Results: We generated iPSCs from a Dravet syndrome patient with a c.4933C>T substitution in SCN1A, which is predicted to result in truncation in the fourth homologous domain of the protein (p.R1645*). Neurons derived from these iPSCs were primarily GABAergic (>50%), although glutamatergic neurons were observed as a minor population (<1%). Current-clamp analyses revealed significant impairment in action potential generation when strong depolarizing currents were injected. Conclusions: Our results indicate a functional decline in Dravet neurons, especially in the GABAergic subtype, which supports previous findings in murine disease models, where loss-of-function in GABAergic inhibition appears to be a main driver in epileptogenesis. Our data indicate that patient-derived iPSCs may serve as a new and powerful research platform for genetic disorders, including the epilepsies.

Original languageEnglish
Article number19
JournalMolecular Brain
Volume6
Issue number1
DOIs
Publication statusPublished - 2013

Fingerprint

Myoclonic Epilepsy
Induced Pluripotent Stem Cells
Neurons
NAV1.1 Voltage-Gated Sodium Channel
Epilepsy
Inborn Genetic Diseases
Action Potentials
Pathology
Research
Population
Genes

Keywords

  • Action potential
  • Disease modeling
  • Dravet syndrome
  • Epileptogenesis
  • Gamma aminobutyric acid
  • Induced pluripotent stem cells
  • Nav1.1
  • SCN1A

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Molecular Biology

Cite this

Higurashi, N., Uchida, T., Lossin, C., Misumi, Y., Okada, Y., Akamatsu, W., ... Hirose, S. (2013). A human Dravet syndrome model from patient induced pluripotent stem cells. Molecular Brain, 6(1), [19]. https://doi.org/10.1186/1756-6606-6-19

A human Dravet syndrome model from patient induced pluripotent stem cells. / Higurashi, Norimichi; Uchida, Taku; Lossin, Christoph; Misumi, Yoshio; Okada, Yohei; Akamatsu, Wado; Imaizumi, Yoichi; Zhang, Bo; Nabeshima, Kazuki; Mori, Masayuki X.; Katsurabayashi, Shutaro; Shirasaka, Yukiyoshi; Okano, Hideyuki; Hirose, Shinichi.

In: Molecular Brain, Vol. 6, No. 1, 19, 2013.

Research output: Contribution to journalArticle

Higurashi, N, Uchida, T, Lossin, C, Misumi, Y, Okada, Y, Akamatsu, W, Imaizumi, Y, Zhang, B, Nabeshima, K, Mori, MX, Katsurabayashi, S, Shirasaka, Y, Okano, H & Hirose, S 2013, 'A human Dravet syndrome model from patient induced pluripotent stem cells', Molecular Brain, vol. 6, no. 1, 19. https://doi.org/10.1186/1756-6606-6-19
Higurashi N, Uchida T, Lossin C, Misumi Y, Okada Y, Akamatsu W et al. A human Dravet syndrome model from patient induced pluripotent stem cells. Molecular Brain. 2013;6(1). 19. https://doi.org/10.1186/1756-6606-6-19
Higurashi, Norimichi ; Uchida, Taku ; Lossin, Christoph ; Misumi, Yoshio ; Okada, Yohei ; Akamatsu, Wado ; Imaizumi, Yoichi ; Zhang, Bo ; Nabeshima, Kazuki ; Mori, Masayuki X. ; Katsurabayashi, Shutaro ; Shirasaka, Yukiyoshi ; Okano, Hideyuki ; Hirose, Shinichi. / A human Dravet syndrome model from patient induced pluripotent stem cells. In: Molecular Brain. 2013 ; Vol. 6, No. 1.
@article{3a7d2f24e84741c0881affe18eea5858,
title = "A human Dravet syndrome model from patient induced pluripotent stem cells",
abstract = "Background: Dravet syndrome is a devastating infantile-onset epilepsy syndrome with cognitive deficits and autistic traits caused by genetic alterations in SCN1A gene encoding the α-subunit of the voltage-gated sodium channel Nav1.1. Disease modeling using patient-derived induced pluripotent stem cells (iPSCs) can be a powerful tool to reproduce this syndrome's human pathology. However, no such effort has been reported to date. We here report a cellular model for DS that utilizes patient-derived iPSCs. Results: We generated iPSCs from a Dravet syndrome patient with a c.4933C>T substitution in SCN1A, which is predicted to result in truncation in the fourth homologous domain of the protein (p.R1645*). Neurons derived from these iPSCs were primarily GABAergic (>50{\%}), although glutamatergic neurons were observed as a minor population (<1{\%}). Current-clamp analyses revealed significant impairment in action potential generation when strong depolarizing currents were injected. Conclusions: Our results indicate a functional decline in Dravet neurons, especially in the GABAergic subtype, which supports previous findings in murine disease models, where loss-of-function in GABAergic inhibition appears to be a main driver in epileptogenesis. Our data indicate that patient-derived iPSCs may serve as a new and powerful research platform for genetic disorders, including the epilepsies.",
keywords = "Action potential, Disease modeling, Dravet syndrome, Epileptogenesis, Gamma aminobutyric acid, Induced pluripotent stem cells, Nav1.1, SCN1A",
author = "Norimichi Higurashi and Taku Uchida and Christoph Lossin and Yoshio Misumi and Yohei Okada and Wado Akamatsu and Yoichi Imaizumi and Bo Zhang and Kazuki Nabeshima and Mori, {Masayuki X.} and Shutaro Katsurabayashi and Yukiyoshi Shirasaka and Hideyuki Okano and Shinichi Hirose",
year = "2013",
doi = "10.1186/1756-6606-6-19",
language = "English",
volume = "6",
journal = "Molecular Brain",
issn = "1756-6606",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - A human Dravet syndrome model from patient induced pluripotent stem cells

AU - Higurashi, Norimichi

AU - Uchida, Taku

AU - Lossin, Christoph

AU - Misumi, Yoshio

AU - Okada, Yohei

AU - Akamatsu, Wado

AU - Imaizumi, Yoichi

AU - Zhang, Bo

AU - Nabeshima, Kazuki

AU - Mori, Masayuki X.

AU - Katsurabayashi, Shutaro

AU - Shirasaka, Yukiyoshi

AU - Okano, Hideyuki

AU - Hirose, Shinichi

PY - 2013

Y1 - 2013

N2 - Background: Dravet syndrome is a devastating infantile-onset epilepsy syndrome with cognitive deficits and autistic traits caused by genetic alterations in SCN1A gene encoding the α-subunit of the voltage-gated sodium channel Nav1.1. Disease modeling using patient-derived induced pluripotent stem cells (iPSCs) can be a powerful tool to reproduce this syndrome's human pathology. However, no such effort has been reported to date. We here report a cellular model for DS that utilizes patient-derived iPSCs. Results: We generated iPSCs from a Dravet syndrome patient with a c.4933C>T substitution in SCN1A, which is predicted to result in truncation in the fourth homologous domain of the protein (p.R1645*). Neurons derived from these iPSCs were primarily GABAergic (>50%), although glutamatergic neurons were observed as a minor population (<1%). Current-clamp analyses revealed significant impairment in action potential generation when strong depolarizing currents were injected. Conclusions: Our results indicate a functional decline in Dravet neurons, especially in the GABAergic subtype, which supports previous findings in murine disease models, where loss-of-function in GABAergic inhibition appears to be a main driver in epileptogenesis. Our data indicate that patient-derived iPSCs may serve as a new and powerful research platform for genetic disorders, including the epilepsies.

AB - Background: Dravet syndrome is a devastating infantile-onset epilepsy syndrome with cognitive deficits and autistic traits caused by genetic alterations in SCN1A gene encoding the α-subunit of the voltage-gated sodium channel Nav1.1. Disease modeling using patient-derived induced pluripotent stem cells (iPSCs) can be a powerful tool to reproduce this syndrome's human pathology. However, no such effort has been reported to date. We here report a cellular model for DS that utilizes patient-derived iPSCs. Results: We generated iPSCs from a Dravet syndrome patient with a c.4933C>T substitution in SCN1A, which is predicted to result in truncation in the fourth homologous domain of the protein (p.R1645*). Neurons derived from these iPSCs were primarily GABAergic (>50%), although glutamatergic neurons were observed as a minor population (<1%). Current-clamp analyses revealed significant impairment in action potential generation when strong depolarizing currents were injected. Conclusions: Our results indicate a functional decline in Dravet neurons, especially in the GABAergic subtype, which supports previous findings in murine disease models, where loss-of-function in GABAergic inhibition appears to be a main driver in epileptogenesis. Our data indicate that patient-derived iPSCs may serve as a new and powerful research platform for genetic disorders, including the epilepsies.

KW - Action potential

KW - Disease modeling

KW - Dravet syndrome

KW - Epileptogenesis

KW - Gamma aminobutyric acid

KW - Induced pluripotent stem cells

KW - Nav1.1

KW - SCN1A

UR - http://www.scopus.com/inward/record.url?scp=84876839257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876839257&partnerID=8YFLogxK

U2 - 10.1186/1756-6606-6-19

DO - 10.1186/1756-6606-6-19

M3 - Article

C2 - 23639079

AN - SCOPUS:84876839257

VL - 6

JO - Molecular Brain

JF - Molecular Brain

SN - 1756-6606

IS - 1

M1 - 19

ER -